Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| HCM | HUTCHMED (CHINA) LTD | $2.02B | 872,335,120 | 0.49% | 0.06% | ||||
| AGI | ALAMOS GOLD INC | $12.08B | 419,860,744 | 56.82% | 0.00% | ||||
| COHU | COHU INC | $2.50B | 47,338,433 | 92.72% | 7.28% | Net Selling | Net Selling | ||
| JBIO | JADE BIOSCIENCES INC | $1.05B | 49,359,875 | 72.82% | 27.18% | Net Buying | |||
| FHTX | FOGHORN THERAPEUTICS INC | $285.35M | 58,713,922 | 75.69% | 14.46% | ||||
| EVMN | EVOMMUNE INC | $472.20M | 36,018,372 | 62.08% | 37.92% | Net Buying | Net Selling | ||
| CAMP | CAMP4 THERAPEUTICS CORP | $216.01M | 51,925,800 | 60.47% | 39.53% | Net Buying | |||
| GPCR | STRUCTURE THERAPEUTICS INC | $3.52B | 213,223,549 | 31.31% | 10.35% | Net Selling | Net Buying | ||
| NOK | NOKIA CORP | $56.96B | 5,742,239,696 | 18.70% | 0.00% | ||||
| MAZE | MAZE THERAPEUTICS INC | $1.53B | 55,345,261 | 88.58% | 11.42% | Net Selling | Net Selling | ||
| ZURA | ZURA BIO LTD | $540.54M | 94,997,710 | 53.86% | 46.14% | Net Buying | |||
| PLYX | POLARYX THERAPEUTICS INC | $105.58M | 47,343,297 | 4.79% | 56.56% | Net Buying | Net Buying | ||
| AVLN | AVALYN PHARMA INC | $1.36B | 44,333,095 | 0.00% | 29.18% | Net Buying | |||
| PALI | PALISADE BIO INC | $359.31M | 173,579,670 | 84.51% | 7.00% | Net Selling | Net Selling | ||
| REA | RARE EARTHS AMERICAS INC | $212.01M | 19,907,282 | 0.00% | 13.02% | ||||
| OVID | OVID THERAPEUTICS INC | $474.07M | 186,640,102 | 56.29% | 9.99% | Net Buying | |||
| ENOV | ENOVIS CORP | $1.78B | 57,562,603 | 42.40% | 57.60% | Net Selling | Net Selling | ||
| LFTO | LIFTOFF MOBILE INC | N/A | 166,480,527 | 0.00% | 81.07% | Net Buying | Net Buying | ||
| XENE | XENON PHARMACEUTICALS INC | $6.19B | 96,665,550 | 97.56% | 2.44% | Net Selling | Net Selling | ||
| TMC | TMC THE METALS CO INC | $1.71B | 433,221,138 | 13.97% | 36.05% | Net Buying | Net Selling | ||
| GFI | GOLD FIELDS LTD | $30.53B | 895,024,247 | 17.51% | 0.01% | Net Buying | Net Buying | ||
| ANGO | ANGIODYNAMICS INC | $627.84M | 41,332,389 | 79.47% | 20.53% | Net Selling | Net Selling | ||
| GIL | GILDAN ACTIVEWEAR INC | $10.51B | 185,188,000 | 81.35% | 0.00% | ||||
| BMEA | BIOMEA FUSION INC | $88.93M | 72,299,440 | 33.68% | 25.19% | Net Buying | |||
| RZLT | REZOLUTE INC | $478.57M | 96,292,331 | 44.44% | 55.56% | Net Buying | Net Selling | ||
| MPLT | MAPLIGHT THERAPEUTICS INC | $586.77M | 45,345,676 | 34.15% | 65.85% | Net Buying | Net Buying | ||
| NTHI | NEONC TECHNOLOGIES HOLDINGS INC | $89.23M | 26,013,136 | 11.15% | 73.51% | Net Buying | |||
| SIND | SINDA LTD | N/A | 148,936,013 | 0.00% | 84.18% | ||||
| ASML | ASML HOLDING NV | $659.79B | 385,417,665 | 18.54% | 0.00% | ||||
| QTTB | Q32 BIO INC | $273.93M | 16,956,415 | 29.15% | 70.85% | Net Buying | Net Buying | ||
| BEAM | BEAM THERAPEUTICS INC | $2.92B | 102,879,214 | 86.62% | 13.38% | Net Selling | Net Selling | ||
| PYXS | PYXIS ONCOLOGY INC | $200.20M | 63,355,482 | 43.52% | 52.84% | Net Buying | Net Buying | ||
| LIME | NEUTRON HOLDINGS INC | N/A | 64,025,936 | 0.00% | 41.01% | Net Buying | Net Buying | ||
| HTHT | H WORLD GROUP LTD | $13.00B | 3,072,694,153 | 4.70% | 0.61% | Net Selling | Net Selling | ||
| GTN | GRAY MEDIA INC | $440.75M | 102,738,455 | 69.47% | 30.53% | Net Buying | Net Selling | ||
| EPRX | EUPRAXIA PHARMACEUTICALS INC | $402.99M | 61,808,630 | 35.57% | 0.00% | ||||
| CBRS | CEREBRAS SYSTEMS INC | $51.46B | 226,532,567 | 0.00% | 6.05% | Net Selling | Net Selling | ||
| HBM | HUDBAY MINERALS INC | $11.00B | 444,144,760 | 66.70% | 0.00% | ||||
| KLRS | KALARIS THERAPEUTICS INC | $102.78M | 23,792,278 | 5.85% | 94.15% | Net Buying | Net Buying | ||
| MOBI | MOBIA MEDICAL INC | $393.67M | 33,249,006 | 0.00% | 30.46% | Net Buying | Net Buying | ||
| CMPS | COMPASS PATHWAYS PLC | $1.59B | 134,949,320 | 68.55% | 21.34% | Net Selling | |||
| STRO | SUTRO BIOPHARMA INC | $425.36M | 16,570,439 | 48.52% | 51.48% | Net Buying | |||
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | $40.12B | 1,165,296,084 | 57.83% | 0.81% | Net Selling | Net Selling | ||
| CP | CANADIAN PACIFIC KANSAS CITY LTD | $79.67B | 879,079,224 | 68.60% | 0.01% | ||||
| TCOM | TRIPCOM GROUP LTD | $30.40B | 648,991,284 | 23.04% | 1.28% | ||||
| FSV | FIRSTSERVICE CORP | $6.24B | 44,154,011 | 71.95% | 0.00% | ||||
| TNGX | TANGO THERAPEUTICS INC | $4.25B | 144,647,982 | 68.39% | 31.61% | Net Selling | Net Buying | ||
| AKBA | AKEBIA THERAPEUTICS INC | $354.10M | 268,258,243 | 37.91% | 8.20% | Net Selling | Net Selling | ||
| ECHO | ECHOSTAR CORP | $26.61B | 290,490,708 | 59.26% | 7.51% | Net Buying | Net Buying | ||
| PCOR | PROCORE TECHNOLOGIES INC | $8.49B | 151,955,338 | 36.02% | 63.98% | Net Selling | Net Selling | ||
| GHRS | GH RESEARCH PLC | $1.81B | 62,029,395 | 76.01% | 23.99% | ||||
| ELTX | ELICIO THERAPEUTICS INC | $60.31M | 19,086,081 | 13.83% | 59.76% | Net Buying | |||
| ITRG | INTEGRA RESOURCES CORP | $446.99M | 202,257,000 | 32.81% | 0.00% | ||||
| PHAR | PHARMING GROUP NV | $726.18M | 707,781,240 | 0.01% | 0.00% | ||||
| LRMR | LARIMAR THERAPEUTICS INC | $426.96M | 103,882,937 | 55.85% | 44.15% | Net Buying | Net Buying | ||
| ASMB | ASSEMBLY BIOSCIENCES INC | $420.20M | 15,892,608 | 51.18% | 48.82% | Net Buying | Net Buying | ||
| MSTR | STRATEGY INC | $37.52B | 384,225,751 | 49.78% | 0.11% | Net Selling | Net Selling | ||
| IMUX | IMMUNIC INC | $191.38M | 13,621,526 | 80.09% | 19.91% | ||||
| ARGX | ARGENX SE | $52.81B | 62,537,923 | 46.08% | 0.00% | ||||
| GMAB | GENMAB A | $18.64B | 64,243,333 | 100.00% | 0.00% | ||||
| NKTR | NEKTAR THERAPEUTICS | $2.46B | 33,786,032 | 52.04% | 47.96% | Net Selling | Net Selling | ||
| ITG | ITG INC | N/A | 121,230,390 | 0.00% | 46.17% | Net Selling | Net Selling | ||
| AGBK | AGI INC | $1.28B | 183,566,434 | 9.05% | 2.00% | Net Buying | Net Buying | ||
| PDS | PRECISION DRILLING CORP | $978.73M | 12,852,644 | 61.97% | 0.00% | ||||
| SABS | SAB BIOTHERAPEUTICS INC | $294.39M | 76,464,094 | 57.16% | 42.84% | Net Buying | |||
| CABA | CABALETTA BIO INC | $451.66M | 163,054,796 | 51.93% | 2.67% | Net Buying | |||
| AGMB | AGOMAB THERAPEUTICS NV | $717.89M | 48,736,779 | 47.92% | 0.09% | ||||
| IRON | DISC MEDICINE INC | $2.99B | 38,392,844 | 62.62% | 37.38% | Net Selling | Net Buying | ||
| DMRA | DAMORA THERAPEUTICS INC | $1.85B | 61,553,194 | 77.24% | 22.76% | Net Selling | Net Selling | ||
| TLX | TELIX PHARMACEUTICALS LTD | $3.49B | 338,777,049 | 0.76% | 7.56% | Net Buying | |||
| SRRK | SCHOLAR ROCK HOLDING CORP | $5.73B | 119,828,338 | 61.89% | 38.11% | Net Buying | Net Selling | ||
| ARVN | ARVINAS INC | $580.69M | 64,521,198 | 70.11% | 29.89% | Net Selling | Net Selling | ||
| ACRS | ACLARIS THERAPEUTICS INC | $835.19M | 139,663,680 | 58.10% | 41.90% | Net Selling | |||
| SSMR | SUNSHINE SILVER MINING & REFINING CO | N/A | 140,840,360 | 0.00% | 100.00% | Net Buying | Net Buying | ||
| AD | ARRAY DIGITAL INFRASTRUCTURE INC | $3.06B | 86,400,000 | 22.40% | 1.00% | Net Selling | Net Buying | ||
| INUV | INUVO INC | $16.15M | 14,820,898 | 5.46% | 94.54% | Net Selling | Net Selling | ||
| ALT | ALTIMMUNE INC | $597.04M | 194,474,154 | 35.67% | 32.64% | Net Buying | Net Buying | ||
| EQ | EQUILLIUM INC | $142.89M | 63,226,556 | 64.05% | 22.25% | Net Selling | Net Selling | ||
| ADTN | ADTRAN HOLDINGS INC | $709.54M | 80,998,100 | 78.25% | 21.75% | Net Selling | Net Selling | ||
| CNTX | CONTEXT THERAPEUTICS INC | $57.15M | 91,879,177 | 86.17% | 1.43% | ||||
| PEPG | PEPGEN INC | $133.50M | 69,169,215 | 80.68% | 9.74% | Net Buying | Net Selling | ||
| BETA | BETA TECHNOLOGIES INC | $5.07B | 230,756,019 | 46.75% | 34.23% | Net Buying | Net Selling | ||
| WPM | WHEATON PRECIOUS METALS CORP | $52.40B | 454,044,000 | 62.05% | 0.00% | ||||
| DCGO | DOCGO INC | $64.40M | 98,778,413 | 42.63% | 26.51% | Net Selling | Net Selling | ||
| CEVA | CEVA INC | $1.01B | 27,859,369 | 70.98% | 29.02% | Net Selling | Net Selling | ||
| QNT | QUANTINUUM INC | N/A | 259,285,571 | 0.00% | 80.87% | Net Buying | Net Buying | ||
| KRRO | KORRO BIO INC | $163.70M | 14,422,571 | 29.10% | 70.90% | Net Buying | Net Selling | ||
| CRVO | CERVOMED INC | $25.92M | 9,258,719 | 2.43% | 97.57% | Net Buying | Net Buying | ||
| STTK | SHATTUCK LABS INC | $607.31M | 76,680,517 | 73.12% | 19.69% | Net Buying | Net Buying | ||
| AHCO | ADAPTHEALTH CORP | $912.92M | 136,054,152 | 45.46% | 54.54% | Net Buying | Net Selling | ||
| AMBA | AMBARELLA INC | $3.61B | 43,868,185 | 71.50% | 28.50% | Net Selling | Net Selling | ||
| AVTX | AVALO THERAPEUTICS INC | $974.04M | 52,565,572 | 27.61% | 72.39% | Net Selling | Net Selling | ||
| ERO | ERO COPPER CORP | $3.02B | 104,277,968 | 66.03% | 0.00% | ||||
| FDMT | 4D MOLECULAR THERAPEUTICS INC | $536.35M | 52,276,254 | 80.12% | 19.88% | Net Selling | Net Selling | ||
| KYMR | KYMERA THERAPEUTICS INC | $8.59B | 82,257,588 | 78.37% | 21.63% | Net Selling | Net Selling | ||
| MSLE | SATELLOS BIOSCIENCE INC | $208.94M | 20,831,190 | 38.33% | 0.00% | ||||
| VEL | VELOCITY FINANCIAL INC | $699.53M | 39,255,281 | 44.45% | 55.55% | Net Buying | Net Buying | ||
| HELP | CYBIN INC | $479.14M | 51,631,804 | 46.70% | 0.00% | ||||
| SGMT | SAGIMET BIOSCIENCES INC | $488.86M | 61,184,313 | 21.83% | 35.74% | Net Selling | Net Selling | ||
| RAPP | RAPPORT THERAPEUTICS INC | $2.02B | 47,826,929 | 77.47% | 22.53% | Net Selling | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.